TI
MYGN icon

Trexquant Investment’s Myriad Genetics MYGN Stock Holding History

Trexquant Investment’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-406,102
Closed -$1.83M – 2114
2026
Q1 		$1.83M Sell
406,102
-136,393
-25% -$711K 0.01% 1037
2025
Q4 		$3.34M Buy
542,495
+143,203
+36% +$1.04M 0.03% 778
2025
Q3 		$2.89M Buy
+399,292
New +$2.37M 0.03% 759
2025
Q2 		– Sell
-107,431
Closed -$953K – 1759
2025
Q1 		$953K Buy
107,431
+15,055
+16% +$181K 0.01% 1107
2024
Q4 		$1.27M Sell
92,376
-42,569
-32% -$785K 0.01% 1019
2024
Q3 		$3.7M Sell
134,945
-75,802
-36% -$2.05M 0.05% 589
2024
Q2 		$5.15M Buy
+210,747
New +$4.62M 0.08% 397
2023
Q3 		– Sell
-27,604
Closed -$640K – 1702
2023
Q2 		$640K Sell
27,604
-31,300
-53% -$683K 0.02% 909
2023
Q1 		$1.37M Buy
58,904
+39,946
+211% +$811K 0.04% 598
2022
Q4 		$275K Buy
+18,958
New +$353K 0.01% 1132
2021
Q1 		– Sell
-12,810
Closed -$253K – 1346
2020
Q4 		$253K Buy
+12,810
New +$207K 0.03% 784
2017
Q2 		– Sell
-37,654
Closed -$723K – 1043
2017
Q1 		$723K Buy
37,654
+9,428
+33% +$167K 0.09% 384
2016
Q4 		$471K Buy
+28,226
New +$511K 0.07% 465
2016
Q3 		– Sell
-51,305
Closed -$1.57M – 898
2016
Q2 		$1.57M Buy
51,305
+31,621
+161% +$1.1M 0.21% 135
2016
Q1 		$737K Buy
+19,684
New +$742K 0.09% 393

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Trexquant Investment's MYGN Position: Q2 2026 in Review

Trexquant Investment sold out of Myriad Genetics (MYGN) in Q2 2026, closing a stake of 406,102 shares — an estimated $1.83M sold.

Trexquant Investment first reported a position in MYGN in Q1 2016 and held it in 15 quarters. The position peaked at $5.15M in Q2 2024. 197 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

  • Trexquant Investment reported no remaining Myriad Genetics position as of Q2 2026 after selling out during the quarter.
  • Trexquant Investment sold 406,102 Myriad Genetics shares in Q2 2026, an estimated $1.83M.
  • Trexquant Investment first reported a position in Myriad Genetics in Q1 2016 and held it in 15 quarters.
  • Trexquant Investment's Myriad Genetics position peaked at $5.15M in Q2 2024.
  • 197 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.